Business

Press Release Jun 05 2025

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 05, 2025, titled "Alvotech and Dr. Reddy s enter into Collaboration toCo-Develop Biosimilar Candidate to Keytruda� (pembrolizumab) for global markets.".

Dr. Reddy's Laboratories Ltd.June 5, 20255
Press Release Jun 05 2025

About this update from Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 05, 2025, titled "Alvotech and Dr. Reddy s enter into Collaboration toCo-Develop Biosimilar Candidate to Keytruda� (pembrolizumab) for global markets.". View Attachment

View stock analysis, news, and events for Dr. Reddy's Laboratories Ltd.

More from Dr. Reddy's Laboratories Ltd.

Dr. Reddy’s Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose ...

August 4, 2026

Dr. Reddy's Laboratories Ltd. Press Release Aug 01 2026

August 1, 2026

All Dr. Reddy's Laboratories Ltd. news →